The effects of REG4 expression on chemoresistance of ovarian cancer

Li-Wei Xiang & Hua-Chuan Zheng et al. · 2022-08-05

Although ovarian cancer usually responds well to platinum- and taxane-based first-line chemotherapy, most patients develop recurrence and chemoresistance. Regenerating gene 4 (REG4) is a secretory protein involved in cell differentiation and proliferation. We found higher REG4 expression in ovarian cancer than in normal tissues (